Art
J-GLOBAL ID:202302223832816713   Reference number:23A3006029

Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)

駆出率が低下した心不全におけるサクビトリル/バルサルタン:イタリアからの実世界の経験(REAL.IT研究)【JST・京大機械翻訳】
Author (15):
Material:
Volume: 12  Issue:Page: 699  Publication year: 2023 
JST Material Number: U7214A  ISSN: 2077-0383  Document type: Article
Article type: 原著論文  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Sacubitril/valsartan reduces h...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=23A3006029&from=J-GLOBAL&jstjournalNo=U7214A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for cardiovascular system diseases  ,  Clinical application of vasoactive drugs and hypotensive drugs 
Reference (31):
  • GBD 2017 Disease Injury and Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1789-1858.
  • Seferović, P.M.; Vardas, P.; Jankowska, E.A.; Maggioni, A.P.; Timmis, A.; Milinković, I.; Polovina, M.; Gale, C.P.; Lund, L.H.; Lopatin, Y. The Heart Failure Association Atlas: Heart failure epidemiology and management statistics 2019. Eur. J. Heart Fail. 2021, 23, 906-914.
  • Piccinni, C.; Antonazzo, I.C.; Simonetti, M.; Mennuni, M.G.; Parretti, D.; Cricelli, C.; Colombo, D.; Nica, M.; Cricelli, I.; Lapi, F. The burden of chronic heart failure in primary care in Italy. High Blood Press Cardiovasc. Prev. 2017, 24, 171-178.
  • Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.G.F.; Coats, A.J.S.; Falk, V.; Gonzalez-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016, 37, 2129-2200.
  • McDonagh, T.A.; Metra, M.; Adamo, M.; Gardner, R.S.; Baumbach, A.; Bohm, M.; Burri, H.; Butler, J.; Celutkiene, J.; Chioncel, O.; et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021, 42, 3599-3726.
more...

Return to Previous Page